Friday, February 20, 2026 | 08:56 PM ISTहिंदी में पढें
Page 4 - Glaxosmithkline
Pfizer Inc deal with GlaxoSmithKline plc will have no India impact
Ruling out any impact on GSK's India business, company sources said in India the pharma entity owned and manufactured products such as Iodex and Ostocalcium, which were marketed by GSK Consumer
 "Pfizer Inc deal with GlaxoSmithKline plc will have no India impact")
Updated On : 20 Dec 2018 | 12:27 AM IST
Pharma giant GSK buys US cancer drugmaker Tesaro for hefty $5.1 bln
Tesaro boosts GSK's pharma portfolio at high price $75/ share; cash from Horlicks sale to help fund pharma investment
 "Pharma giant GSK buys US cancer drugmaker Tesaro for hefty $5.1 bln")
Updated On : 04 Dec 2018 | 1:11 AM IST
Glaxo seeks mid-Sept bids for $4 billion Indian Horlicks unit: Report
The company is assessing its 72.5 per cent holding in India-listed GlaxoSmithKline Consumer Healthcare Ltd. as part of that process
 "Glaxo seeks mid-Sept bids for $4 billion Indian Horlicks unit: Report")
Updated On : 21 Aug 2018 | 7:28 PM IST
GlaxoSmithKline may split up group, spin off consumer division: Report
Some investors have long called for the group's break-up, arguing that it would crystallise value for component businesses
Updated On : 21 Jul 2018 | 11:40 AM IST